Data / Drug companies / Carisoprodol
Carisoprodol: 28 companies and 54 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Carisoprodol is listed in the FDA National Drug Code Directory by 28 companies, with 54 products in commercial distribution. 51 of the products (94.4%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are tablet, and the newest product started marketing on December 1, 2025.
The request: Get every company that lists carisoprodol in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 28
- Products
- 54
- Generic (ANDA) products
- 51 (94.4%)
- Application numbers
- 9
- Controlled substance schedule
- Schedule IV
- Routes
- Oral
- Brand names
- Soma
- openFDA record search
- api.fda.gov
Companies that list carisoprodol
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Bryant Ranch Prepack | 5 | tablet | Generic drugs (ANDA) | June 11, 2025 |
| Bryant Ranch Prepack | 5 | tablet | Generic drugs (ANDA) | January 20, 2020 |
| Asclemed USA, Inc. | 3 | tablet | Generic drugs (ANDA) | November 8, 2016 |
| Bryant Ranch Prepack | 3 | tablet | Generic drugs (ANDA) | June 11, 2025 |
| PD-Rx Pharmaceuticals, Inc. | 3 | tablet | Generic drugs (ANDA) | May 11, 2025 |
| Proficient Rx LP | 3 | tablet | Generic drugs (ANDA) | January 20, 2020 |
| A-S Medication Solutions | 2 | tablet | Generic drugs (ANDA) | January 20, 2020 |
| Aphena Pharma Solutions - Tennessee, LLC | 2 | tablet | Generic drugs (ANDA) | January 20, 2020 |
| Aurobindo Pharma Limited | 2 | tablet | Generic drugs (ANDA) | November 8, 2016 |
| Direct_Rx | 2 | tablet | Generic drugs (ANDA) | October 12, 2022 |
| NuCare Pharmaceuticals,Inc. | 2 | tablet | Generic drugs (ANDA) | January 27, 2014 |
| Remedyrepack Inc. | 2 | tablet | Generic drugs (ANDA) | July 14, 2023 |
| Rising Pharma Holdings, Inc. | 2 | tablet | Generic drugs (ANDA) | November 8, 2016 |
| Viatris Specialty LLC | 2 | tablet | New drug applications (NDA) | September 8, 2007 |
| Westminster Pharmaceuticals, LLC | 2 | tablet | Generic drugs (ANDA) | November 25, 2025 |
| Wilshire Pharmaceuticals, Inc. | 2 | tablet | Generic drugs (ANDA) | February 15, 2017 |
| Advanced Rx of Tennessee, LLC | 1 | tablet | Generic drugs (ANDA) | March 31, 2023 |
| Chartwell RX, LLC | 1 | tablet | Generic drugs (ANDA) | August 8, 2019 |
| Direct RX | 1 | tablet | Generic drugs (ANDA) | July 26, 2019 |
| Granulation Technology, Inc. | 1 | tablet | Generic drugs (ANDA) | June 11, 2025 |
| Ingenus Pharmaceuticals, LLC | 1 | tablet | Generic drugs (ANDA) | May 21, 2019 |
| Medsource Pharmaceuticals | 1 | tablet | Generic drugs (ANDA) | January 20, 2020 |
| Mylan Pharmaceuticals Inc. | 1 | tablet | Authorized generics (NDA) | October 1, 2016 |
| Northwind Health Company, LLC | 1 | tablet | Generic drugs (ANDA) | August 1, 2024 |
| Oxford Pharmaceuticals, LLC | 1 | tablet | Generic drugs (ANDA) | January 20, 2020 |
| ScieGen Pharmaceuticals, Inc. | 1 | tablet | Generic drugs (ANDA) | January 27, 2014 |
| St. Mary's Medical Park Pharmacy | 1 | tablet | Generic drugs (ANDA) | December 1, 2025 |
| Strides Pharma Inc. | 1 | tablet | Generic drugs (ANDA) | July 31, 2014 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 54 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 51 | 94.4% |
| New drug applications (NDA) | 2 | 3.7% |
| Authorized generics (NDA) | 1 | 1.9% |
Pharmacologic classes
| Class | Products |
|---|---|
| Muscle Relaxant | 54 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.